About 10x Genomics
What 10x Genomics is building
Technologies used at 10x Genomics
React
Typescript
Vue.js
AngularCompany culture
A Passion for Innovation
As a member of the 10x Genomics team, you’ll become an integral part of helping our customers innovate.
Collaborate and Grow
Behind every breakthrough is an extensive network of talented individuals contributing their unique perspectives, backgrounds, and areas of expertise. This kind of collaboration is essential to building a strong and effective workplace, and it’s our goal to create an inclusive environment that reflects the diversity of the communities and the goals we serve. The discoveries we make now, as a team, will lead to better technologies, better treatments, and a better future.
Funding rounds
Total Funding
Last funding round type
Company type
10x Genomics news and updates
10x Genomics, Inc. launched commercial shipments of Xenium platform for in situ analysis on Dec 8th 22'.
10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the first commercial shipments of its Xenium platform for in situ analysis.
Dec 7, 2022 | alcancercongress.orgNanoString Technologies, Inc. filed suit against 10x Genomics, Inc. on Oct 17th 22'.
NanoString Technologies last month filed a lawsuit against 10x Genomics for alleged patent infringement.
Nov 17, 2022 | genomeweb.com10x Genomics, Inc. had issues with patent infringement on Aug 26th 21'.
10x Genomics has sued Parse Biosciences, a competitor in the single-cell transcriptomics market, alleging patent infringement.
Aug 26, 2022 | genomeweb.com10x Genomics, Inc. launches Visium Spatial Gene Expression solution
10x Genomics had launched its Visium Spatial Gene Expression solution just a few months earlier, and targeted, highly resolved methods, such as Bio-Techne's ACD RNAScope could handle just a few different genes at a time.
Jun 13, 2022 | genomeweb.comElement Biosciences, Inc. partnered with 10x Genomics, Inc. on Feb 28th 22'.
Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with 10x Genomics, a life sciences leader focused on mastering biology to advance human health, that demonstrates the seamless integration of the Element AVITI ™ System and 10x Genomics’ single cell technologies.
Jan 1, 2022 | businesswire.com10x Genomics, Inc. launched low-cost single-cell instrument Chromium Single Cell Controller on Oct 1st 16'.
Moreover, in October 2016, California-based 10x Genomics introduced its new, low-cost single-cell instrument Chromium Single Cell Controller, a massively scalable tool for comprehensive single-cell analysis, which is based on microfluidics consumables based on GemCode Technology.
Jan 1, 2022 | einnews.com10x Genomics, Inc. launches series of product updates
10x Genomics, Inc. (Nasdaq: TXG ), a life sciences leader focused on mastering biology to advance human health, today announced a series of product updates that will be presented at the 2022 Advances in Genome Biology and Technology (AGBT) General Meeting this week in Orlando, Fla.
Jan 1, 2022 | prnewswire.com10x Genomics, Inc. will hire Jim Wilbur as Chief Commercial Officer on Jul 27th 22'.
Following a comprehensive search process, 10x Genomics, Inc. (Nasdaq: TXG), today announced the hiring of Jim Wilbur, Ph.D., as Chief Commercial Officer, effective July 27.
Jan 1, 2022 | kplctv.com10x Genomics, Inc. decreased headcount by 100 on Aug 3rd 22'.
10x Genomics has laid off approximately 8 percent of its full-time employees, or about 100 people, the firm disclosed in a regulatory filing with the US Securities and Exchange Commission on Wednesday.
Jan 1, 2022 | genomeweb.comBullard leaves 10x Genomics, Inc. as senior director of sales for the Americas
Bullard also joins Singular from 10x Genomics, where he was senior director of sales for the Americas.
Jan 1, 2022 | genomeweb.com10x Genomics, Integrated DNA Technologies (IDT), and Sartorius Receive Top Honors at Life Science Industry Awards
BioInformatics Inc., part of Science and Medicine Group, the leading research and advisory firm serving the life science tools market, today announced that nine companies have been selected for a Life Science Industry Award for launching one of the most innovative new products in 2021.
Dec 8, 2021 | Cision PR Newswire10x Genomics Recognized on The Scientist's Top 10 Innovations List for Fifth Consecutive Year
10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced that Chromium X has been named one of The Scientist's 2021 Top 10 Innovations, an annual list of newly released products that have the potential to generate the biggest impact on scientific research.
Dec 1, 2021 | Cision PR Newswire10x Genomics Celebrates Opening of Singapore Manufacturing and Commercial Hub
10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today marked a major Asia Pacific (APAC) expansion with the grand opening celebration of its Singapore manufacturing facility and commercial hub.
Oct 25, 2021 | Cision PR Newswire